MIRA Pharmaceuticals Statistics
Share Statistics
MIRA Pharmaceuticals has 16.92M
shares outstanding. The number of shares has increased by 12.04%
in one year.
| Shares Outstanding | 16.92M |
| Shares Change (YoY) | 12.04% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 115 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 455.31K, so 2.69% of the outstanding
shares have been sold short.
| Short Interest | 455.31K |
| Short % of Shares Out | 2.69% |
| Short % of Float | 3.49% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.24 and the forward
PE ratio is -3.46.
MIRA Pharmaceuticals's PEG ratio is
0.1.
| PE Ratio | -2.24 |
| Forward PE | -3.46 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 8 |
| P/FCF Ratio | -3.17 |
| PEG Ratio | 0.1 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for MIRA Pharmaceuticals.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.99,
with a Debt / Equity ratio of 0.
| Current Ratio | 3.99 |
| Quick Ratio | 3.99 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-3,926,329.5 |
| Employee Count | 2 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 63.39% in the
last 52 weeks. The beta is 1.98, so MIRA Pharmaceuticals's
price volatility has been higher than the market average.
| Beta | 1.98 |
| 52-Week Price Change | 63.39% |
| 50-Day Moving Average | 1.11 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 63.35 |
| Average Volume (20 Days) | 1,290,887 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.02M |
| Net Income | -7.85M |
| EBITDA | -7.85M |
| EBIT | -7.69M |
| Earnings Per Share (EPS) | -0.51 |
Full Income StatementBalance Sheet
The company has 2.83M in cash and 0 in
debt, giving a net cash position of 2.83M.
| Cash & Cash Equivalents | 2.83M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -29.14M |
| Total Assets | 1.4M |
| Working Capital | 1.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -5.56M
and capital expenditures 0, giving a free cash flow of -5.56M.
| Operating Cash Flow | -5.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | -5.56M |
| FCF Per Share | -0.36 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
